hotspot -WSS

hotspot

author：explore 2025-09-27 12:47:18 - browse：75138

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： 2024 GOP presidential candidates spar over abortion in debate

WSS

With measles on the rise, a personal story of a devastating disease

Feds fine Medicare Advantage plans for overcharging members

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

It's time to retire 'poor historian' from clinicians' vocabularies

Appeals court upholds limits to abortion pill

Radiation, mainstay of cancer treatment, begins a fade

explore

hotspot

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Wearables generate powerful data but its not useful to doctors, yet

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

With measles on the rise, a personal story of a devastating disease

How to save PrEP access — and even expand it

Complete sequence of Y chromosome published for first time

United colonoscopy coverage change 'may cost lives,' doctors say

Australia’s approach to dialysis celebrates life

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

When prostate cancer spreads, where it goes matters

hotspot

Australia’s approach to dialysis celebrates life

HIV vaccine remains elusive. Immunologists keep trying new ideas

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Medicare explains how it will choose drugs for negotiation

Helping hospitals and community health centers plan for resilience

focus

focus

focus

explore